| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
REVIEW ARTICLE |
Meningococcal Reference Unit, Manchester PHL, Withington Hospital, Manchester and *Immunisation Division, PHLS Communicable Disease Surveillance Centre, 61 Colindale Avenue, London NW9 5EQ
Corresponding author: Dr E. Miller (e-mail: Emiller{at}phls.org.uk).
Received 15 April 2002; accepted 18 April 2002.
Abstract
This review details the impact of the introduction of meningococcal serogroup C conjugate (MCC) vaccines in the UK. An overall reduction of 86.7% in the incidence of serogroup C infection in the targeted age groups has been observed from 1999 to 2001, with a concomitant decrease in deaths, from 67 in 1999 to 5 in 2001. The enhanced surveillance programme initiated to complement the introduction of MCC vaccines has been essential in generating data relating to vaccine coverage, vaccine failures and efficacy estimates. Vaccine coverage has exceeded 80% in all age groups targeted and up to the end of 2001, 25 confirmed and 1 probable vaccine failure have been observed in England and Wales. Efficacy estimates for England up to September 2001 were 91.5% in infants receiving three doses of MCC vaccine and 89.3% in toddlers receiving one dose of MCC vaccine (England). There is some evidence of herd immunity in unvaccinated cohorts of the target age groups, ranging from a reduction in disease incidence of 34% in 9–14 year olds to 61% in 15–17 year olds. Surveillance of the genotypic and phenotypic characteristics of invasive and carriage isolates has shown no evidence to date of capsular switching from serogroup C to serogroup B.
This article has been cited by other articles:
|
|
 |
|
  K Cathie, M Levin, and S N Faust Drug use in acute meningococcal disease Arch. Dis. Child. Ed. Pract., October 1, 2008; 93(5): 151 - 158. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Jemmett, A. Macagno, M. Molteni, J. E. Heckels, C. Rossetti, and M. Christodoulides A Cyanobacterial Lipopolysaccharide Antagonist Inhibits Cytokine Production Induced by Neisseria meningitidis in a Human Whole-Blood Model of Septicemia Infect. Immun., July 1, 2008; 76(7): 3156 - 3163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C. Fusco, E. K. Farley, C.-H. Huang, S. Moore, and F. Michon Protective Meningococcal Capsular Polysaccharide Epitopes and the Role of O Acetylation Clin. Vaccine Immunol., May 1, 2007; 14(5): 577 - 584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. N. Williams, P. J. Skipp, H. E. Humphries, M. Christodoulides, C. D. O'Connor, and J. E. Heckels Proteomic Analysis of Outer Membranes and Vesicles from Wild-Type Serogroup B Neisseria meningitidis and a Lipopolysaccharide-Deficient Mutant Infect. Immun., March 1, 2007; 75(3): 1364 - 1372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. F. Tsai, R. Borrow, H. E. Gnehm, B. Vaudaux, U. Heininger, D. Desgrandchamps, C. Aebi, P. Balmer, R. D. Pedersen, B. Fritzell, et al. Early appearance of bactericidal antibodies after polysaccharide challenge of toddlers primed with a group C meningococcal conjugate vaccine: what is its role in the maintenance of protection? Clin. Vaccine Immunol., August 1, 2006; 13(8): 854 - 861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Huo, R. Sinha, E. A. McNeela, R. Borrow, R. Giemza, C. Cosgrove, P. T. Heath, K. H. G. Mills, R. Rappuoli, G. E. Griffin, et al. Induction of Protective Serum Meningococcal Bactericidal and Diphtheria-Neutralizing Antibodies and Mucosal Immunoglobulin A in Volunteers by Nasal Insufflations of the Neisseria meningitidis Serogroup C Polysaccharide-CRM197 Conjugate Vaccine Mixed with Chitosan Infect. Immun., December 1, 2005; 73(12): 8256 - 8265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Birtles, K. Hardy, S. J. Gray, S. Handford, E. B. Kaczmarski, V. Edwards-Jones, and A. J. Fox Multilocus Sequence Typing of Neisseria meningitidis Directly from Clinical Samples and Application of the Method to the Investigation of Meningococcal Disease Case Clusters J. Clin. Microbiol., December 1, 2005; 43(12): 6007 - 6014. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Diggle and S. C. Clarke Increased Genetic Diversity of Neisseria meningitidis Isolates after the Introduction of Meningococcal Serogroup C Polysaccharide Conjugate Vaccines J. Clin. Microbiol., September 1, 2005; 43(9): 4649 - 4653. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Newcombe, J. C. Jeynes, E. Mendoza, J. Hinds, G. L. Marsden, R. A. Stabler, M. Marti, and J. J. McFadden Phenotypic and Transcriptional Characterization of the Meningococcal PhoPQ System, a Magnesium-Sensing Two-Component Regulatory System That Controls Genes Involved in Remodeling the Meningococcal Cell Surface J. Bacteriol., July 15, 2005; 187(14): 4967 - 4975. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Pichichero Meningococcal Conjugate Vaccine in Adolescents and Children Clinical Pediatrics, July 1, 2005; 44(6): 479 - 489. [Abstract] [PDF]
|
|
|
|
|
|
Y. Al-Mazrou, M. Khalil, R. Borrow, P. Balmer, J. Bramwell, G. Lal, N. Andrews, and M. Al-Jeffri Serologic Responses to ACYW135 Polysaccharide Meningococcal Vaccine in Saudi Children under 5 Years of Age Infect. Immun., May 1, 2005; 73(5): 2932 - 2939. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W. Shepard, I. R. Ortega-Sanchez, R. D. Scott II, N. E. Rosenstein, and and the ABCs Team Cost-Effectiveness of Conjugate Meningococcal Vaccination Strategies in the United States Pediatrics, May 1, 2005; 115(5): 1220 - 1232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Buttery, A. Riddell, J. McVernon, T. Chantler, L. Lane, J. Bowen-Morris, L. Diggle, R. Morris, A. Harnden, S. Lockhart, et al. Immunogenicity and Safety of a Combination Pneumococcal-Meningococcal Vaccine in Infants: A Randomized Controlled Trial JAMA, April 13, 2005; 293(14): 1751 - 1758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Z. Jordens, J. N. Williams, G. R. Jones, M. Christodoulides, and J. E. Heckels Development of Immunity to Serogroup B Meningococci during Carriage of Neisseria meningitidis in a Cohort of University Students Infect. Immun., November 1, 2004; 72(11): 6503 - 6510. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R S Heyderman, Y Ben-Shlomo, C A Brennan, and M Somerset The incidence and mortality for meningococcal disease associated with area deprivation: an ecological study of hospital episode statistics Arch. Dis. Child., November 1, 2004; 89(11): 1064 - 1068. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Welsch and D. Granoff Naturally Acquired Passive Protective Activity against Neisseria meningitidis Group C in the Absence of Serum Bactericidal Activity Infect. Immun., October 1, 2004; 72(10): 5903 - 5909. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Regev-Yochay, R. Dagan, M. Raz, Y. Carmeli, B. Shainberg, E. Derazne, G. Rahav, and E. Rubinstein Association Between Carriage of Streptococcus pneumoniae and Staphylococcus aureus in Children JAMA, August 11, 2004; 292(6): 716 - 720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Baraldo, E. Mori, A. Bartoloni, R. Petracca, A. Giannozzi, F. Norelli, R. Rappuoli, G. Grandi, and G. Del Giudice N19 Polyepitope as a Carrier for Enhanced Immunogenicity and Protective Efficacy of Meningococcal Conjugate Vaccines Infect. Immun., August 1, 2004; 72(8): 4884 - 4887. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Joseph, P. Balmer, M. Bybel, T. Papa, R. Ryall, and R. Borrow Assignment of Neisseria meningitidis Serogroups A, C, W135, and Y Anticapsular Total Immunoglobulin G (IgG), IgG1, and IgG2 Concentrations to Reference Sera Clin. Vaccine Immunol., January 1, 2004; 11(1): 1 - 5. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Newcombe, L.-J. Eales-Reynolds, L. Wootton, A. R. Gorringe, S. G. P. Funnell, S. C. Taylor, and J. J. McFadden Infection with an Avirulent phoP Mutant of Neisseria meningitidis Confers Broad Cross-Reactive Immunity Infect. Immun., January 1, 2004; 72(1): 338 - 344. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Offit and G. Peter The Meningococcal Vaccine -- Public Policy and Individual Choices N. Engl. J. Med., December 11, 2003; 349(24): 2353 - 2356. [Full Text] [PDF]
|
|
|
|
 |
|
 V. Davenport, T. Guthrie, J. Findlow, R. Borrow, N. A. Williams, and R. S. Heyderman Evidence for Naturally Acquired T Cell-Mediated Mucosal Immunity to Neisseria meningitidis J. Immunol., October 15, 2003; 171(8): 4263 - 4270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yi, D. S. Stephens, and I. Stojiljkovic Development and Evaluation of an Improved Mouse Model of Meningococcal Colonization Infect. Immun., April 1, 2003; 71(4): 1849 - 1855. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |
